InvestorsHub Logo

georgejjl

03/02/19 2:42 PM

#183506 RE: XenaLives #183505

dadofmarcmax, What do you think about the following:

ANAVEX 2-73 also shows synergistic activity with three generations of epilepsy drugs currently on the market:
ETS (Zaronrin®), VPA (Depakene®) and Gabapentin (Neurontin®)



https://anavex.com//wp-content/uploads/ANAVEX-2-73-as-a-Potential-Treatment-for-Rett-Syndrome.pdf

Good luck and GOD bless,

Amatuer17

03/02/19 3:24 PM

#183513 RE: XenaLives #183505

MS - where does MS come in play for Anavex?

Did you see Biogen applies for a new MS drug?

A2-73 does not appear anywhere in MS circle

Alkermes and Biogen Announce U.S. Food and Drug Administration Acceptance of Diroximel Fumarate New Drug Application for Multiple Sclerosis https://s.yimg.com/lo/api/res/1.2/_r0oNHSpEba3wwqfXay7Rg--/YXBwaWQ9eXZpZGVvZmVlZHM7dz0xO2g9MQ--/http://globalfinance.zenfs.com/en_us/Finance/US_AFTP_GlobeNewsWire_EmailNotif_LIVE/ti?nf=NzU0ODM0NyMyNzk2NDY0IzIwMDk2ODQ= https://finance.yahoo.com/news/alkermes-biogen-announce-u-food-123000175.html